Evaluation of LB in THA

NCT03341104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 173

Last updated 2017-11-14

No results posted yet for this study

Summary

This study aims to compare the effectiveness of liposomal bupivacaine (LB) versus standard of practice local injection containing plain bupivacaine.

Conditions

  • Hip Disease

Interventions

DRUG

Bupivacaine liposome

Replace bupivacaine with bupivacaine liposome

Sponsors & Collaborators

  • University of Illinois College of Medicine at Peoria

    collaborator OTHER
  • OSF Healthcare System

    lead OTHER

Principal Investigators

  • Ed Rainville · OSF HealthCare Ssytem

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-01
Primary Completion
2016-07-30
Completion
2016-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03341104 on ClinicalTrials.gov